Ikena Oncology, Inc. (IKNA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ikena Oncology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 0.00x | -19.29x | -14.47x | -16.80x | -158.68x | -121.37x |
| P/B Ratio | 0.00x | 7.54x | 5.81x | 7.86x | 26.04x | -53.16x |
| P/S Ratio | 0.00x | 0.00x | 107.71x | 73.96x | 174.71x | 584.21x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 88.9% | 87.0% | -52.0% | -387.8% |
| Operating Margin | 0.0% | 0.0% | -823.3% | -454.0% | -110.2% | -484.2% |
| Net Margin | 0.0% | 0.0% | -744.2% | -440.3% | -110.1% | -481.4% |
| EBITDA Margin | 0.0% | 0.0% | -812.2% | -449.2% | -108.4% | -481.0% |
| Liquidity | ||||||
| Current Ratio | 0.00x | 11.80x | 12.58x | 7.44x | 8.70x | 5.86x |
| Quick Ratio | 0.00x | 11.80x | 12.58x | 7.44x | 8.70x | 5.86x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.06x | 0.06x | 0.04x | 0.03x | -0.00x |
YoY = year-over-year change. Source: FMP..